Scoliosis and Genetic Testing: The Rise, Fall and Future of Predicting Curves
Scoliosis and Genetic Testing: The Rise, Fall and Future of Predicting Curves
If scoliosis runs in your family, it is natural to wonder whether a simple DNA test could tell you who will develop a curve, or whose curve will worsen. For a few years, one test promised exactly that. Its story, a genuine rise and fall, is one of the most instructive in scoliosis care, and it explains why genetics, however fascinating, has not yet changed the day-to-day approach to catching and managing curves. Here is the honest picture of what genetic testing can and cannot tell you about scoliosis today.
Is scoliosis hereditary?
Partly, yes. Scoliosis often clusters in families, and twin studies show that if one identical twin has adolescent idiopathic scoliosis (AIS), the other is considerably more likely to have it too. But "heritable" is not the same as "caused by one gene." AIS is what scientists call a complex, polygenic trait: many genes each contribute a small amount of risk, interacting with growth and other factors. That is precisely why a single, clean genetic test has proven so hard to build.
The rise: a test that promised to predict progression
Around 2009 to 2010, a commercial saliva-based DNA test (best known as ScoliScore) was launched for children with mild AIS. It analysed a panel of genetic markers and returned a low, intermediate or high score, intended to estimate how likely a small curve was to progress to a severe one. The appeal was obvious and humane: if a test could reassure low-risk families and spare them years of anxious monitoring or bracing, while flagging high-risk children for closer attention, that would be a real step toward personalised scoliosis care.
The fall: when the evidence didn't hold up
The promise did not survive independent testing. When other research groups tried to validate the markers in their own patient populations, the test's ability to predict progression largely failed to replicate, and it performed poorly outside the specific population it was developed in. As the evidence accumulated, confidence collapsed and the test was eventually withdrawn from the market. The lesson was sobering but important: because AIS progression is influenced by many genes and by growth, a handful of markers simply could not carry the predictive weight that had been hoped for.
What we have learned since
The science has genuinely advanced. Large genome-wide studies have identified real scoliosis susceptibility genes, including LBX1, GPR126 (also called ADGRG6), POC5 and BNC2, among others. These discoveries help explain why scoliosis develops and confirm its biological basis. But there is a crucial distinction: these genes are associated with the risk of having scoliosis, not with reliably predicting whose curve will progress. Polygenic risk scores that combine many markers are an active and promising area of research, but for now they remain research tools, not validated clinical predictors.
The honest state of play today
As things stand, there is no validated genetic test that reliably tells an individual whether they will develop scoliosis or how far a curve will progress. Genes load the dice; they do not determine the outcome. A strong family history is a reason for greater vigilance and earlier screening, not a verdict, and an absent family history does not guarantee safety, since most children with AIS have no affected relative at all. Genes are risk, not destiny.
What actually helps right now
While the genetics matures, the proven path is reassuringly practical and within everyone's reach:
- Early detection — simple screening, including the forward-bend (Adam's) test and a scoliometer reading, catches curves early when there are more options.
- Monitoring through growth — because curves can change quickly during growth spurts, regular review during adolescence matters far more than any one-off prediction.
- Early conservative intervention — when a curve is identified, scoliosis-specific exercise and bracing where indicated can help manage it, with the best opportunities coming from acting early.
In other words, what a genetic test once hoped to offer, an early warning, is already delivered, far more reliably, by attentive screening and monitoring.
The ScolioLife perspective
We follow the genetics closely, because understanding why scoliosis develops will one day improve how we predict and personalise care. But we base today's care on what is proven: early detection, careful monitoring through growth, and a multimodal, non-surgical programme of scoliosis-specific exercise, the ScolioAlign™ 3D brace where indicated, and regular review. If scoliosis runs in your family, the most useful step is not a DNA test but a simple check for your children and siblings. You can read more about the genetics of scoliosis, about spotting scoliosis in children, try our scoliometer screening tool, and explore our scoliosis treatment programme and patient results.
Frequently asked questions
Is scoliosis genetic?
It has a genetic component, and it can run in families, but it is polygenic and complex rather than caused by a single gene. Many people with scoliosis have no family history at all.
Can a test tell me if my child will get scoliosis or whether the curve will worsen?
Not reliably. The earlier commercial test that claimed to predict progression was withdrawn after independent studies could not confirm it, and no validated replacement exists yet. Screening and monitoring remain the dependable approach.
Should my other children or siblings be checked?
Yes. A family history raises the value of simple screening. Catching a curve early gives the most options, so a quick check is worthwhile.
If no one else in the family has scoliosis, are we safe?
Not necessarily. Most adolescent idiopathic scoliosis occurs in children with no affected relatives, which is why routine screening matters regardless of family history.
Is ScoliScore still available?
No. The test is no longer on the market. Current best practice relies on clinical screening, growth monitoring and early conservative care rather than genetic prediction.
The bottom line
The story of scoliosis genetic testing is a useful reminder to be hopeful about science but careful about hype. A genetic test may one day help personalise scoliosis care, and research is moving in that direction, but that day is not here yet. For now, the most powerful tools remain the simplest ones: look early, monitor through growth, and act early when a curve appears. Genes may load the dice, but early detection and good care still shape the outcome.
Every scoliosis case is different, and early assessment may help identify progression risks. UK patients fly direct to Singapore in around 13 hours for focused, non-surgical programmes at our Singapore, Kuala Lumpur or Surabaya clinics. Get in touch with ScolioLife to arrange an evaluation for yourself or your child.